BioLife Solutions, Inc. (BLFS) ownership: Top institutional holder: T. Rowe Price Investment Management, Inc. ($124.14M). Insider activity: Net Seller (0 buys, 20 sells). 3 recent congressional STOCK Act disclosures. SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 6506346.00 | $124.14M | 2026-03-31 |
| BlackRock, Inc. | 6101765.00 | $116.42M | 2026-03-31 |
| Casdin Capital, LLC | 5957165.00 | $113.66M | 2026-03-31 |
| VANGUARD GROUP INC | 3087386.00 | $74.65M | 2025-12-31 |
| Invesco Ltd. | 2348532.00 | $44.81M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1917708.00 | $36.59M | 2026-03-31 |
| STATE STREET CORP | 1577076.00 | $30.09M | 2026-03-31 |
| FMR LLC | 1470252.00 | $28.05M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-08 | |
| Sell | null | 2026-06-08 | |
| Sell | null | 2026-06-08 | |
| Sell | null | 2026-05-19 | |
| Sell | null | 2026-05-19 | |
| Sell | null | 2026-05-19 | |
| Sell | null | 2026-04-08 | |
| Sell | null | 2026-04-08 |
Back to BLFS overview · BLFS earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.